Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05223868
What this trial is testing

JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 255
Early research (Phase 1)Study completedNCT05728489
What this trial is testing

Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 64
Large-scale testing (Phase 3)Study completedNCT01358578
What this trial is testing

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 1,306
Post-approval studies (Phase 4)Study completedNCT00663052
What this trial is testing

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis
Pfizer 273
Large-scale testing (Phase 3)Study completedNCT03412747
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Plaque Psoriasis
UCB Biopharma SRL 478
Not applicableStudy completedNCT04053881
What this trial is testing

Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

Who this might be right for
Plaque Psoriasis
UCB Biopharma SRL 412
Not applicableStudy completedNCT02713295
What this trial is testing

Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie 273
Not applicableActive Not RecruitingNCT06104644
What this trial is testing

Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 550
Post-approval studies (Phase 4)WithdrawnNCT04614298
What this trial is testing

Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Co., Ltd.
Early research (Phase 1)Study completedNCT01937260
What this trial is testing

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT06109818
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd. 129
Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177
Early research (Phase 1)Looking for participantsNCT07038720
What this trial is testing

UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisHealthy Volunteer
Usynova Pharmaceuticals Ltd. 124
Large-scale testing (Phase 3)Study completedNCT03589885
What this trial is testing

Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Looking for participantsNCT07672561
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Zhejiang Wenda Pharma Technology LTD. 375
Large-scale testing (Phase 3)Study completedNCT02595970
What this trial is testing

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT05495568
What this trial is testing

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Celltrion 367
Testing effectiveness (Phase 2)Study completedNCT00329303
What this trial is testing

Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
UCB Pharma 71
Large-scale testing (Phase 3)Looking for participantsNCT06979453
What this trial is testing

Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 366
Testing effectiveness (Phase 2)Study completedNCT02908347
What this trial is testing

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Who this might be right for
PsoriasisPlaque Psoriasis
MetrioPharm AG 46
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation